TrialTransplantation proceedings1997

Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.

M A Nalesnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.